期刊文献+

蛋白酶体抑制剂可增加足叶乙甙对白血病细胞系M-07e和TF-1的凋亡诱导效应 被引量:2

Enhanced Apoptosis-inducing Effect of Etoposide on Leukemic Ce ll Lines M-07e and TF-1 by the Proteasome Inhibitor Z-LLL-CHO
下载PDF
导出
摘要 近年来的研究显示泛素 蛋白酶体通路在细胞凋亡调控中发挥了重要的作用。本实验就蛋白酶体抑制剂Z LLL CHO与经典的凋亡诱导剂足叶乙甙 (VP16)对白血病细胞系M 0 7e及TF 1的联合效应进行了初步研究。应用MTT法及台盼蓝拒染法显示Z LLL CHO及VP16联合作用于M 0 7e及TF 1细胞 ,可增强两种药物单独的细胞杀伤效应。流式细胞术检测提示单独应用Z LLL CHO及VP16均可使S +G2 /M期细胞比例增加 ,两者联合应用导致细胞凋亡峰比例的显著增高。通过对M 0 7e细胞裂解物做免疫印迹检测 ,发现在Z LLL CHO及VP16单独作用中均导致Bcl 2蛋白被酶解为 2 2kD的片段 ,而联合作用时Bcl 2的酶解现象具有叠加效应。结论 :Z LLL CHO与VP16联合作用较单独作用有更强的细胞杀伤及诱导细胞凋亡活性 ,细胞周期S +G2 /M期比例的增加及Bcl 2酶解片段的增加是导致蛋白酶体抑制剂Z LLL CHO及VP16对白血病细胞系联合效应的可能机制。 Recent researches indicate that ubiquitin-prot ea some pathway plays an important role in apoptosis regulation. Proteasome inhibit ors induce apoptosis in many kinds of neoplastic cells, thus provide a great opp ortunity for exploring synergy of proteasome inhibitors and other apoptosis-ind ucing agents. In this study, the effect of the proteasome inhibitor Z-LLL-CHO combined with etoposide (VP16) on leukemic cell lines M-07e and TF-1 was inves tigated by MTT assay, trypan blue exclusion, flow cytometry and Western blot. Th e results showed that the combination of Z-LLL-CHO and VP16 was much more effe ctive than either agents alone in promoting cytotoxicity in both cell lines eval uated. Accumulation of cells in S+G 2/M phase of the cell cycle was observed in the cells treated with VP16 and Z-LLL-CHO alone, while apparent increase of s ub-G 0/G 1 fraction was detected in cells treated with combination of the agents. The cleavage of Bcl-2 into a shortened 22 kD fragment was detected in M -07e cells e xposed to either agents alone, and the fraction of 22 kD fragment was increased in the cells treated with conbination of the agents. In conclusion, the combinat i on of Z-LLL-CHO and VP16 enhanced their individual cytotoxic effect by induci ng apoptosis, in which increase of S+G 2/M fraction in cell cycle as well as th e enhanced cleavage of Bcl-2 are the possible mechanism of the additive effect on leukemic cells by Z-LLL-CHO and VP16.
出处 《中国实验血液学杂志》 CAS CSCD 2003年第5期485-489,共5页 Journal of Experimental Hematology
关键词 蛋白酶体抑制剂 足叶乙甙 细胞凋亡 白血病细胞系 M—07e TF-1 proteasome inhibitor etoposide apoptosis leukem ic cell line M-07e TF-1
  • 相关文献

参考文献13

  • 1兰雨,张学敏,胡美茹,杨怡,杨平地,沈倍奋.阻断泛素-蛋白酶体通路诱导白血病细胞凋亡及机制探讨[J].中国实验血液学杂志,2001,9(2):105-109. 被引量:5
  • 2Hirsch T, Dallaporta B, Zamzami N, et al. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J Immunol, 1998; 161:35-40.
  • 3Tabata M, Tabata R, Grabowski DR, et al. Roles of NF-кB and 26 S proteasome in apoptotic cell death induced by topoisomerase Ⅰ and Ⅱ poisons in human nonsmall cell lung carcinoma. J Biol Chem,2001 ; 276:8029 - 8036.
  • 4Fadeel B, Hassan Z, Hellstrom-Lindberg E, et al. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia, 1999; 13: 719- 728.
  • 5Cheng EH, Kirsch DC, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 1997; 278:1966 - 1968.
  • 6Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis.Cell Death Differ, 1999; 6:303 -313.
  • 7Sayers TJ, Brooks/kiD, Koh CY, et al. The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood, 2003; [epub ahead of print].
  • 8Cory AH, CoryJG. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NF-kappaB activation, on drug-resistant mouse leukemia L1210 cells. Anticancer Res, 2002; 22(6C) : 3805 - 3809.
  • 9Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apopto6is for primary human leukemic stem cells. Proc Natl Acad Sci USA, 2002; 99: 16220- 16225.
  • 10Watanabe K, Kubota M, Hamahata K, et al. Prevention of etoposide-induced apopto6is by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappa B activation. Biochem Pharmacol, 2000; 60: 823- 830.

二级参考文献10

  • 1Adams J, Palombella VJ, Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res, 1999; 59:2615 - 2622
  • 2Orlowski RZ. The role of the ubiquitin-proteasome pathwayin apoptosis. Cell Death Differ, 1999; 6:303- 313
  • 3Drexler HC. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA,1997; 94:855 - 860
  • 4Zhang XM, Lin H, Chen C, et al. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease andinduces Bcl-2 cleavage in human M-07e leukaemic cells.Biochem J, 1999; 340(Pt 1): 127- 133
  • 5Chen C, Lin H, Karanes C, et al. Human THP-1 mono-cytic leukemic cells induced to undergo monocytic differenti-ation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis. Cancer Res, 2000; 60:4377- 4385
  • 6Izban KF, Wrone-Smith T, Hsi ED, et al. Characteriza-tion of the interleukin-1beta-converting enzyme/ced-3-familyprotease, caspase-3/CPP32, in Hodgkin′s disease: lack ofcaspase-3 expression in nodular lymphocyte predominanceHodgkin′s disease. Am J Pathol, 1999; 154:1439-1447
  • 7Cheng EH, Kirsch DG, Clem RJ, et al. Conversion ofBcl-2 to a Bax-like death effector by caspases. Science,1997; 278:1966 - 1968
  • 8Thomberry NA, Lazebnik Y. Caspases: enemies within.Science, 1998; 281:1312 - 1316
  • 9.SwantonE,SavoryP,CosulichS,etal.Bcl-2regulatesacaspase-3/caspase-2apoptoticcascadeincytosolicextracts.Oncogene,1999;18:1781-1787
  • 10胡美茹,兰雨,张学敏,沈倍奋.Caspase与Bcl-2在凋亡发生和调控中的相互作用机制[J].军事医学科学院院刊,2000,24(2):126-129. 被引量:19

共引文献4

同被引文献17

  • 1李晨,张政,李玉英,王转花.重组荞麦胰蛋白酶抑制剂理化性质的研究[J].食品科学,2006,27(8):52-56. 被引量:5
  • 2狄春红,顾少华,谭晓华,仙玲,和桂芬,季超能,杨磊.As_2O_3对NB4细胞增殖及凋亡的影响[J].中国公共卫生,2006,22(9):1134-1136. 被引量:8
  • 3扶云碧,孙启鑫,孟凡义,谢军,周光飚.蛋白酶体抑制剂硼替佐米诱导髓系白血病细胞株 HL60凋亡的机制研究[J].中华医学杂志,2006,86(34):2413-2416. 被引量:14
  • 4Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med Res Rew, 2003 ; 23 : 535 - 558
  • 5Yavelow J, Finlay TH, Kennedy AR, et al. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res, 1983 ; 43(5 Suppl) : 2454s-2459s
  • 6Ren W, Qiao Z, Wang H, et al. Molecular basis of Fas and cytochrome c pathways of apoptosis induced by tartary buckwheat flavonoid in HL-60 cells. Methods Find Exp Clin Pharmacol, 2003,25:431 -436
  • 7Foehr MW, Tomei LD, Goddard JG, et al. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids. Nutr Cancer, 1999 ; 34 : 199 - 205
  • 8Inoue K, Takano H, Yanagisawa R, et al. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopoly sacchatide. Exp Biol Med, (Maywood) 2005; 230:281 -287
  • 9Cai X,Shen YL,Zhu Q. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia[J].Leukemia:Official Journal of the Leukemia Society of America Leukemia Research Fund U K,2000,(02):262-270.doi:10.1038/sj.leu.2401650.
  • 10Horton TM,Gannavarapu A,Blaney SM. Bortezomib interactions with chemotherapy agents in acute leukemia in vitro[J].Cancer Chemotherapy and Pharmacology,2006,(01):13-23.doi:10.1007/s00280-005-0135-z.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部